scholarly journals NRP/B, a Novel Nuclear Matrix Protein, Associates With p110RB and Is Involved in Neuronal Differentiation

1998 ◽  
Vol 141 (3) ◽  
pp. 553-566 ◽  
Author(s):  
Tae-Aug Kim ◽  
Jinkyu Lim ◽  
Setsuo Ota ◽  
Sandhya Raja ◽  
Rick Rogers ◽  
...  

The nuclear matrix is defined as the insoluble framework of the nucleus and has been implicated in the regulation of gene expression, the cell cycle, and nuclear structural integrity via linkage to intermediate filaments of the cytoskeleton. We have discovered a novel nuclear matrix protein, NRP/B (nuclear restricted protein/brain), which contains two major structural elements: a BTB domain–like structure in the predicted NH2 terminus, and a “kelch motif” in the predicted COOH-terminal domain. NRP/B mRNA (5.5 kb) is predominantly expressed in human fetal and adult brain with minor expression in kidney and pancreas. During mouse embryogenesis, NRP/B mRNA expression is upregulated in the nervous system. The NRP/B protein is expressed in rat primary hippocampal neurons, but not in primary astrocytes. NRP/B expression was upregulated during the differentiation of murine Neuro 2A and human SH-SY5Y neuroblastoma cells. Overexpression of NRP/B in these cells augmented neuronal process formation. Treatment with antisense NRP/B oligodeoxynucleotides inhibited the neurite development of rat primary hippocampal neurons as well as the neuronal process formation during neuronal differentiation of PC-12 cells. Since the hypophosphorylated form of retinoblastoma protein (p110RB) is found to be associated with the nuclear matrix and overexpression of p110RB induces neuronal differentiation, we investigated whether NRP/B is associated with p110RB. Both in vivo and in vitro experiments demonstrate that NRP/B can be phosphorylated and can bind to the functionally active hypophosphorylated form of the p110RB during neuronal differentiation of SH-SY5Y neuroblastoma cells induced by retinoic acid. Our studies indicate that NRP/B is a novel nuclear matrix protein, specifically expressed in primary neurons, that interacts with p110RB and participates in the regulation of neuronal process formation.

2006 ◽  
Vol 175 (4S) ◽  
pp. 317-317
Author(s):  
Shahrokh F. Shariat ◽  
Michael Marberger ◽  
Yair Lotan ◽  
Marta Sanchez-Carbayo ◽  
Craig D. Zippe ◽  
...  

2016 ◽  
Vol 150 (4) ◽  
pp. S1090
Author(s):  
Shunhei Yamashina ◽  
Kousuke Izumi ◽  
Yoshihiro Inami ◽  
Tomonori Aoyama ◽  
Akira Uchiyama ◽  
...  

2000 ◽  
Vol 261 (1) ◽  
pp. 166-179 ◽  
Author(s):  
Josef Gotzmann ◽  
Christopher Gerner ◽  
Michael Meissner ◽  
Klaus Holzmann ◽  
Rudolf Grimm ◽  
...  

2000 ◽  
Vol 275 (34) ◽  
pp. 26649-26660 ◽  
Author(s):  
Travis J. Antes ◽  
Jean Chen ◽  
Allen D. Cooper ◽  
Beatriz Levy-Wilson

2021 ◽  
Vol 16 (10) ◽  
pp. 59-62
Author(s):  
Mohamed J. Saadh

Bladder cancer (BC) is the most important tumor problem of urologic cancer. Therefore, noninvasive urinary biomarkers were used for diagnosis of BC. However, the new biomarkers failed to reach higher accuracy. The aim of this study was to assess the diagnostic efficacy of nuclear matrix protein-22 (NMP- 22), nuclear matrix protein-52 (NMP-52), urinary cytology and to investigate combinations of urine NMP-52 with urinary cytology as noninvasive biomarkers to increase diagnostic performance of bladder cancer at different grades and stages. Overall, there were 156 subjects (62 BC, 54 cystitis patients and 40 healthy volunteers). The NMP-22 and NMP-52 were quantified in urine samples by ELISA. The urinary cytology is used by some physicians routinely for diagnosis of BC. The sensitivity and specificity for NMP-52 were 94% and 82%, for NMP-22 69% and 80.8% and for cytology 56% and 94.6% respectively and also, both urinary NMP-22 and NMP-52 have extremely significant relation (p<0.0001) to BC vs. healthy individuals and cystitis patients. Moreover, the combination of NMP- 52 with urinary cytology could predict all BC stages and grade with 95.6% sensitivity and 94.3% specificity. In conclusion, NMP-52 and urinary cytology in combination improve diagnostic performance for BC detection in different pathological types.


2005 ◽  
Vol 96 (3) ◽  
pp. 334-339 ◽  
Author(s):  
Abdelfattah M. Attallah ◽  
Hanem A. Sakr ◽  
Hisham Ismail ◽  
El-Sayed K. Abdel-Hady ◽  
Ibrahim El-Dosoky

1992 ◽  
Vol 202 (2) ◽  
pp. 243-251 ◽  
Author(s):  
Arjan de Graaf ◽  
Alexandra M.L. Meijne ◽  
A.Jos B.M. van Renswoude ◽  
Bruno M. Humbel ◽  
Paul M.P. van Bergen en Henegouwen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document